Physician profile
Jeffrey Malumed
NPI 1134176845
$3,243.14
in general payments reported to CMS, 2019-2025
21 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $402 · 2021: $752 · 2022: $515 · 2023: $410 · 2024: $293 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $580.53 | 2019-2025 | Monovisc, Orthovisc |
| Pacira Therapeutics, INC. | $564.66 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $477.36 | 2022-2025 | Gel-One Cross-Linked Hyaluronate, Tapestry |
| Dynasplint Systems INC. | $246.63 | 2021 | |
| Bioventus LLC | $216.11 | 2019-2024 | L360 Thigh System, Durolane, Durolane |
| Ermi LLC | $179.57 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $175.62 | 2019-2025 | Euflexxa |
| Sanofi-Aventis U.S. LLC | $149.44 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $117.92 | 2022-2023 | Seglentis |
| Electronic Waveform Lab, INC. | $100.13 | 2019-2023 | |
| Stryker Corporation | $87.66 | 2019-2022 | |
| Fidia Pharma USA INC. | $85.44 | 2019-2025 | Hymovis |
| Avanos Medical | $65.16 | 2019-2021 | |
| Smith+Nephew, INC. | $52.36 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $32.59 | 2021-2024 | Xiaflex |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $23.20 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $21.08 | 2021 | |
| Globus Medical, INC. | $20.63 | 2024 | Distal Radius II |
| Orthogenrx INC. | $16.98 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.07 | 2019 | |
| Zyla Life Sciences, INC. | $14.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Malumed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.